/Investor DB

AN Venture Partners — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Capacity Biocapacitybio.cominDec 2022

Capacity Bio is a biotechnology company developing mitophagy modulators — small molecules, peptides, and nanoparticles that target mitochondrial biology to identify and clear dysfunctional mitochondria.

BiotechDeep TechLongevityPalo Alto, US

Amy Wang(PhD)inKenneth Horne(Executive Officer, Director)inDylan Morris(Director)inCristina Ghenoiu(Director)in

BoardTaro Inaba(Director)in

Co-investorsRemiges Ventures, Inc.Insight PartnersRA CapitalRDiscovery

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.